Surgery
Volume 133, Issue 1 , Pages 5-12 , January 2003

Determining an appropriate threshold for referral to surgery for gastroesophageal reflux disease

,Accepted 16 July 2002.

References 

  1. Behar J, Sheahan D, Biancani P, Spinro H, Storer E. Medical and surgical managment of reflux esophagitis. N Engl J Med. 1975;293:263–268
  2. Spechler SJ, for the Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group . Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. N Engl J Med. 1992;326:786–792
  3. Spechler S, Lee E, Ahnen D, Goyal RK, Hirano I, Ramirez F, et al.  Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA. 2001;285:2331–2338
  4. Lundell L, Miettinen P, Myrvold H, Pedersen SA, Thor K, Lamm M, et al.  Long-term management of gastro-oesophageal reflux disease with omeprazole or open antireflux surgery results of a prospective, randomized clinical trial. Eur J Gastroenterol. 2000;12:879–887
  5. Bammer T, Hinder R, Klaus A, Klinger P. Five- to eight-year outcome of the first laparoscopic Nissen fundoplications. J Gastrointest Surg. 2001;5:42–48
  6. Liu J, Wolosin S, Laycock W, Schwartz L. Late outcomes after laparoscopic surgery for gastroesophageal reflux. Arch Surg. 2002;137:397–401
  7. Finlayson S, Birkmeyer J, Laycock W. Trends in surgery for gastroesophageal reflux disease: the effect of laparoscopic surgery on utilization. In: Annual Meeting of the International Society of Technology Assessment in Health Care. Philadelphia, Pa. June 2001;
  8. Sonnenberg F, Beck J. Markov models in medical decision making: a practical guide. Med Decis Making. 1993;13:322–338
  9. DATA 3.5. 3.5 ed. Williamstown, MA: TreeAge Software, Inc; 1999;
  10. Torrance G. Utility apporach to measuring health-related quality of life. J Chronic Dis. 1987;40:593–600
  11. The National Center for Health Statistics . Report of final mortality statistics. Vol 47. Washington, DC: US Public Health Service; 1996; no. 7
  12. Lipscomb J, Weinstein MC, Torrance GW. In:  Gold M,  Siefel J,  Russell L,  Weinstein M editor. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996;p. 214–246
  13. Baladi J, Menon D, Otten N. An economic evluation of finesteride for treatment of benign prostatic hyperplasia. Pharmacoeconomics. 1996;9:443–454
  14. Sculpher M, Michaels J, McKenna M. A cost-utility analysis of laser-assisted angioplasty for peripheral arterial occlusion. Int J Technol Assess Health Care. 1996;12:104–125
  15. Johnson J, Coons S, Ergo A, Szava-Kovats G. Valuation of EuroQol (EQ-5D) health states in an adult US sample. Pharmacoeconomics. 1998;4:421–433
  16. Brooks R. EuroQol: the current state of play. Health Policy. 1996;37:53–72
  17. Brazier J, Jones N, Kind P. Testing the validity of the Euroqol and comparing it with the SF-36 Health Survey questionnaire. Qual Life Res. 1993;2:169–180
  18. Llach X, Herdman M, Schiaffino A. Determining correspondence between scores on the EQ-5D “Thermometer” and a 5-point categorical rating scale. Med Care. 1999;37:671–677
  19. Nease R, Kneeland T, O'Connor G, Sumner W, Lumpkins L, Shaw L, et al.  Variation in patient utilites for outcomes of the managment of chronic stable angina. JAMA. 1995;273:1185–1190
  20. Llewellyn-Thomas H, Sutherland H, Tibshirani R, Ciampi A, Till J, Boyd N. Describing health states: methodologic issues in obtaining values for health states. Med Care. 1984;22:543–552
  21. Read J, Quinn R, Berwick D, Fineberg H, Weinstein M. Preferences for health outcomes: comparison of assessment methods. Med Decis Making. 1984;4:315–329
  22. Heudebert GR, Marks R, Wilcox M, Centor RM. Choice of long-term strategy for the management of patients with severe esophagitis: a cost-utility analysis. Gastoenterol. 1997;112:1078–1086
  23. Myrvold HE, Lundell L, Miettinen P, Pedersen SA, Liedman B, Hatlebakk J, et al.  The cost of long term therapy for gastro-oesophageal reflux disease: a randomised trial comparing omeprazole and open antireflux surgery. Gut. 2001;49:488–494
  24. Lundell L, Dalenback J, Janatuinen E, Hattlebakk J, Levander K, Miettinen P, et al.  Comprehensive 1-year cost analysis of open antireflux surgery in Nordic countries. Br J Surg. 1998;85:1002–1005
  25. Bloomston M, Zervos E, Gonzalez R, Albrink M, Rosemurgy A. Quality of life and antireflux medication use following laparoscopic Nissen fundoplication. Am Surg. 1998;64:509–514
  26. Heikkinen T, Haukipuro K, Koivukangas P, Sorasto A, Autio R, Sodervik H, et al.  Comparison of costs between laparoscopic and open Nissen fundoplication: a prospective randomized study with 3-month followup. J Am Coll Surg. 1999;188:368–376
  27. Viljakka M, Nevalainen J, Isolauri J. Lifetime costs of surgical versus medical treatment of severe gastro-oesophageal reflux disease in Finland. Scand J Gastoenterol. 1997;32:766–772
  28. Van Den Boom G, Go PMMYH, Hameeteman W, Dallemagne B. Cost effectiveness of medical versus surgical treatment in patients with severe or refractory gastroesophgeal reflux disease in The Netherlands. Scand J Gastoenterol. 1996;31:1–9
  29. Hinder R, Filipi C, Wetscher G, Neary P, DeMeester T, Perdikis G. Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease. Ann Surg. 1994;220:472–483
  30. Collett D, Cadiere G. Conversions and complications of laparoscopic treatment of gastroesophageal reflux disease: formation for the Development of Laparoscopic Surgery for Gastroesophageal Reflux Disease Group. Am J Surg. 1995;169:622–626
  31. Medina L, Veintimilla R, Williams M, Fenoglio M. Laparoscopic fundoplication. J Laparoendosc Surg. 1996;6:219–226
  32. Cadiere G, Himpens J, Rajan A, Muls V, Lemper JC, Bruyns J, et al.  Laparoscopic Nissen fundoplication: laparoscopic dissection technique and results. Hepatogastroenterology. 1997;44:4–10
  33. Fingerhut A, Etienne J, Millat B, Comandella M. Laparoscopic antireflux surgery—technique and results. Therapeutische Umschau. 1997;54:492–499
  34. Landreneau R, Wiechmann R, Hazelrigg S, Santucci TS, Boley TM, Magee MJ, et al.  Success of laparoscopic fundoplication for gastroesophageal reflux disease. Ann Thorac Surg. 1998;66:1886–1893
  35. Peters JH, DeMeester TR, Crookes P, Oberg S, de Vos Shoop M, Hagen JA, et al.  The treatment of gastroesophageal reflux disease with laparoscopic Nissen fundoplication: prospective evaluation of 100 patients with “typical” symptoms. Ann Surg. 1998;228:40–50
  36. Ritter M, Peters J, DeMeester T, Crookes PF, Mason RJ, Green L, et al.  Outcome after laparoscopic fundoplication is not dependent on a structurally defective lower esophageal sphincter. J Gastrointest Surg. 1998;2:567–572
  37. Hunter J, Smith C, Branum G, Waring JP, Trus TL, Cornwell M, et al.  Laparoscopic fundoplication failures: patterns of failure and response to fundoplication revision. Ann Surg. 1999;230:595–599
  38. Rantanen TK, Salo JA, Sipponen JT. Fatal and life-threatening complications in antireflux surgery: analysis of 5502 operations. Br J Surg. 1999;86:1573–1577
  39. Soper N, Dunnegan D. Anatomic fundoplication failure after laparoscopic antireflux surgery. Ann Surg. 1999;229:669–675
  40. Bais JE, Bartelsman JFWM, Bonjer HJ, Cuesta MA, Go PM, Klinkenberg-Knol EC, et al.  Laparoscopic or conventional Nissen fundoplication for gastro-oesophageal reflux disease: randomised clinical trial. Lancet. 2000;355:170–174
  41. Rattner DW, Brooks DC. Patient satisfaction following laparoscopic and open antireflux surgery. Arch Surg. 1995;130:289–294
  42. Dallemagne B, Weerts J, Jehaes C, Markiewicz S. Causes of failures of laparoscopic antireflux operations. Surg Endosc. 1996;10:305–310
  43. Stein H, Feussner H, Siewert J. Failure of antireflux surgery: causes and management strategies. Am J Surg. 1996;171:36–40
  44. Curet MJ, Josloff RK, Schoeb O, Zucker KA. Laparoscopic reoperation for failed antireflux procedures. Arch Surg. 1999;134:559–563
  45. Floch N, Hinder R, Klingler P, Branton SA, Seelig MH, Bammer T, et al.  Is laparoscopic reoperation for failed antireflux surgery feasible?. Arch Surg. 1999;134:733–737
  46. Horgan S, Phol D, Bogetti D, Eubanks R, Pellegrini C. Failed antireflux surgery: what have we learned from reoperation?. Arch Surg. 1999;134:809–817
  47. Pointner R, Bammer T, Then P, Kamolz T. Laparoscopic refundoplications after failed antireflux surgery. Am J Surg. 1999;178:541–544
  48. Bass E, Steinberg E, Pitt H. Cost-effectiveness of extracorporeal shock-wave lithotripsy versus cholecystectomy for symptomatic gallstones. Gastoenterol. 1991;101:189–199
  49. Wong J, Koff B, Rine F. Cost-effectiveness of interferon-alpha-2b treatment for hepatitis B e antigen-positive chornic hepatitis B. Ann Intern Med. 1995;122:664–675
  50. Kellett J, Clarke J. Comparison of “accelerated” tissue plasminogen activator with streptokinase for treatment of suspected acute myocardial infarction. Med Decis Making. 1995;15:297–310
  51. Sarasin F, Eckman M. Management and prevention of thromboembolic events in patients with cancer-related hypercoagulable states: a risky business. J Gen Intern Med. 1993;8:476–486
  52. Danese M, Powe N, Sawin C. Screening for mild thyroid failure at the periodic health examination. JAMA. 1996;276:285–292

☆ Dr Finlayson and Dr Birkmeyer are supported by Career Development Awards from the VA Health Services Research and Development program.

☆☆ The views expressed herein do not necessarily represent those of the Department of Veterans Affairs or the United States government.

★ Reprint requests: Dr Jean Y. Liu, VA Surgery (112), Department of Veterans Affairs Hospital, White River Junction, VT 05009.

★★ 0039-6060/2003/$30.00 + 0

PII: S0039-6060(02)21628-1

doi: 10.1067/msy.2003.122

Surgery
Volume 133, Issue 1 , Pages 5-12 , January 2003

Article Tools

* Image Usage & Resolution